RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX): Price and Financial Metrics
RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX)
Today's Latest Price: $25.60 USD
Updated Jan 27 8:50am
Add RELX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 260 in Financial Services (Enterprise)
See all "A" rated Strong Buy stocks
RELX Stock Summary
- RELX has a higher market value than 95.49% of US stocks; more precisely, its current market capitalization is $49,994,534,257.
- Of note is the ratio of Relx Plc's sales and general administrative expense to its total operating expenses; 87.92% of US stocks have a lower such ratio.
- In terms of volatility of its share price, RELX is more volatile than merely 2.46% of stocks we're observing.
- Stocks that are quantitatively similar to RELX, based on their financial statements, market capitalization, and price volatility, are DG, PGR, HUM, NOC, and KDP.
- RELX's SEC filings can be seen here. And to visit Relx Plc's official web site, go to www.relx.com.
RELX Stock Price Chart Interactive Chart >
RELX Price/Volume Stats
| Current price | $25.60 | 52-week high | $27.25 |
| Prev. close | $25.88 | 52-week low | $16.81 |
| Day low | $25.60 | Volume | 4,473 |
| Day high | $25.60 | Avg. volume | 495,387 |
| 50-day MA | $24.38 | Dividend yield | 1.39% |
| 200-day MA | $23.06 | Market Cap | 49.44B |
RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX) Company Bio
RELX PLC provides information solutions for professional customers in North America and Europe. The companys Scientific, Technical & Medical segment publishes research, reference, and education content; and offers database and workflow solutions for scientists, academic institutions, educators, research leaders and administrators, medical researchers, doctors, nurses, and allied health professionals and students, as well as hospitals, research institutions, health insurers, managed healthcare organizations, research-intensive corporations, and governments. The company was founded in 1894 and is based in London, United Kingdom.
RELX Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $25.60 | $15.75 | -39% |
Below please find a table outlining a discounted cash flow forecast for RELX, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Relx Plc ranked in the 39th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Relx Plc, consider:
- Relx Plc's weighted average cost of capital (WACC) is 8%; for context, that number is higher than merely 24.99% of tickers in our DCF set.
- RELX's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than merely 24.99% of tickers in our DCF set.
- Relative to other stocks in its sector (Consumer Cyclical), Relx Plc has a reliance on debt greater than only 22.27% of them.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -40% |
| 1% | -40% |
| 2% | -39% |
| 3% | -39% |
| 4% | -38% |
| 5% | -37% |
For other companies in the Consumer Cyclical that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as RELX, try DPZ, HAS, SIRI, UFI, and GHG.
Loading social stream, please wait...